Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Omeros Corp (OMER)  
$3.15 0.09 (2.94%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 61,650,000
Market Cap: 194.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $7.57
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 25,000 25,000 25,000
Total Buy Value $0 $40,500 $40,500 $40,500
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 0 0 10,000 10,000
Total Sell Value $0 $0 $64,950 $64,950
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 125
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-02-19 4 AS $22.64 $226,400 D/D (10,000) 14,000 -37%     
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-02-19 4 OE $10.27 $102,700 D/D 10,000 24,000     -
   Hood Leroy E. Md Phd   –       •      –    2021-02-12 4 OE $4.53 $22,650 D/D 5,000 74,390     -
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-02-10 4 AS $22.49 $42,731 D/D (1,900) 14,000 -30%     
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-02-10 4 OE $10.27 $19,513 D/D 1,900 15,900     -
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-01-20 4 OE $9.37 $93,700 D/D 10,000 14,000     -
   Jacobsen Michael A VP FINANCE AND CAO   •       –      –    2021-01-19 4 AS $19.95 $189,525 D/D (9,500) 4,000 -22%     
   Cable Thomas J.   –       •      –    2021-01-13 4 AS $16.97 $84,850 D/D (5,000) 35,067 -13%     
   Cable Thomas J.   –       •      –    2021-01-13 4 OE $4.53 $22,650 D/D 5,000 40,067     -
   Cable Thomas J.   –       •      –    2020-05-13 4 AS $14.40 $71,999 D/D (5,000) 35,067 -28%     
   Cable Thomas J.   –       •      –    2020-05-13 4 OE $5.92 $29,600 D/D 5,000 40,067     -
   Hood Leroy E. Md Phd   –       •      –    2020-03-13 4 OE $5.92 $29,600 D/D 5,000 69,390     -
   Hood Leroy E. Md Phd Director   –       •      –    2019-12-14 4 OE $7.56 $75,600 D/D 10,000 64,390     -
   Demopulos Peter A Md Director   –       •      –    2019-12-14 4 OE $7.56 $25,205 D/D 3,334 188,516     -
   Cable Thomas J. Director   –       •      –    2019-12-03 4 AS $14.41 $144,148 D/D (10,000) 35,067     -
   Cable Thomas J. Director   –       •      –    2019-12-03 4 OE $7.56 $75,600 D/D 10,000 45,067     -
   Cable Thomas J. Director   –       •      –    2019-10-14 4 AS $15.12 $75,590 D/D (5,000) 35,067     -
   Cancelmo Peter B See RemarksOfficer   •       –      –    2019-06-10 3 IO $0.00 $0 D/D 0 200     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2019-06-07 4 OE $6.05 $60,500 D/D 10,000 210,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-08-31 4 OE $4.10 $79,269 D/D 15,529 200,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-08-31 4 AS $25.31 $193,846 D/D (7,529) 192,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-08-30 4 AS $24.45 $855,750 D/D (35,000) 192,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-08-30 4 OE $4.10 $143,500 D/D 35,000 227,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-27 4 AS $21.73 $124,357 D/D (5,723) 192,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-27 4 OE $4.10 $23,464 D/D 5,723 198,368     -
  125 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us